Found 11 matching trials
Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine
PHASE2The purpose of this study is to collect serum samples to evaluate serologic...
Location
Benchmark Research Austin
Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants
PHASE1This is a phase 1, randomized, double-blind multi-center, placebo-controlle...
Location
Fukui Aiiku Hospital
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
PHASE2The purpose of this study is to evaluate the efficacy of the Norovirus (NoV...
Location
Great Lakes Naval Station
Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults
PHASE2The purpose of this study is to evaluate the safety of the norovirus bivale...
Location
California Research Foundation
Recombinant, Bivalent, Norovirus Vaccine Study
PHASE1This clinical study will evaluate the vaccine candidate rNV-2v, which is un...
Location
Center for Vaccinology (CEVAC), Ghent University and University Hospital
Bivalent Norovirus Vaccine Study
PHASE1Randomized, multi-site, dose-escalation study of the safety and immunogenic...
Location
Navy Medical Research Center
Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population
PHASE2The purpose of this study is to further develop a formulation and dose regi...
Location
Simon Williamson Clinic
Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine
PHASE2The purpose of this study is to select the optimal formulation of the norov...
Location
Universiteit Antwerpen
Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults
PHASE2The purpose of this study is to evaluate descriptively the long-term immuno...
Location
Simon-Williamson Clinic/Synexus Clinical Research US, Inc
Norovirus Bivalent-Vaccine Efficacy Study
PHASE1The purpose of this study is to determine whether the norovirus vaccine is ...